Lorenza Rimassa

Lorenza Rimassa is an Associate Professor of Oncology at Humanitas University and Head of the Hepatopancreatobiliary Oncology and Hematology Unit at IRCCS Humanitas Research Hospital. She is actively involved in both clinical and academic leadership, including directing residency programs and serving on PhD program boards.

Education:

• Medical School Degree, University of Milan, Italy (1993)
• Residency Program in Medical Oncology, University of Milan, Italy (1993–1997)

Lorenza Rimassa's research focuses on hepatopancreatobiliary malignancies, particularly liver, pancreatic, and biliary tract cancers. Her work integrates molecular oncology and precision medicine approaches to improve therapeutic outcomes. She is deeply involved in clinical trials and translational research, particularly through collaborations with international bodies such as EORTC and NCI.

Lorenza Rimassa holds several prestigious academic and institutional appointments, including leadership roles in international oncology associations and national guideline committees. Her scientific contributions are reflected in her active participation in major research networks focused on liver and biliary cancers.

Scientific and Institutional Honors:

• Treasurer, Executive Committee and Governing Board, International Liver Cancer Association (ILCA)
• Chair, EORTC Hepatopancreatobiliary and Neuroendocrine Tumors Task Force
• Special Expert, Hepatobiliary Task Force, National Cancer Institute (NCI, US)
• Member, Management Committee, COST Action CA22125 "Precision medicine in biliary tract cancer" (Precision-BTC-Network)
• Member, Scientific Committee, Swiss Liver Cancer Foundation
• Co-chair, Technical Commission, Lombardy Oncology Network on liver and biliary tract cancer (Italy)
• Member, Group of Experts, Strategic Committee for the National Guideline System (SNLG), Italian Ministry of Health – ISS

Lorenza Rimassa has held key teaching roles at Humanitas University, including in the Medical School, MedTec program, and Nursing degrees. She has directed the Residency Program in Medical Oncology and contributed to PhD programs in data science in medicine. She leads a specialized clinical unit and is involved in national and international research collaborations, though specific grants or advising details are not listed.

She is affiliated with the Humanitas Cancer Center and contributes to the broader Humanitas Group, a leading research and teaching hospital in Italy.